Company InNexus Biotechnology, Inc. Other OTC
Equities
IXSBF
CA45771Q1046
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Canada
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,325 | 0 | 0 | 92.40 % |
Stock B | 1 | 163,201,977 | 150,799,507 ( 92.40 %) | 0 | |
Stock C | 0 | 467,188 | 0 | 0 |
Company contact information
InNexus Biotechnology, Inc.
1500 Royal Centre 1055 West Georgia Street
V6E 4N7, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |